Description
The Department of Veterans Affairs is seeking to acquire 1050 Plasmax Plasma Concentration System kits. The system is designed to produce a fully autologous plasma concentrate with elevated fibrinogen concentration, which is optimal for haemostasis. The system consists of two parts: the GPS III Separator and the Plasmax Concentrator. The GPS III Separator produces leukocyte-rich platelet-rich plasma (L-PRP) from a small sample of the patient's own blood, while the Plasmax Concentrator produces autologous fibrinogen-rich platelet-poor plasma concentrate (PPPc) using polyacrylamide beads to remove excess water. The system's autologous output eliminates concerns regarding pooled blood sources and provides a safer alternative to donor-based fibrin sealants.
Key features of the system include:
* Outputs up to 10 cc of rapidly polymerizing autologous plasma concentrate
* Outputs up to 3 or 6 cc of PRP, depending on which GPS III kit is being used
* Produces both outputs in less than 20 minutes
* Autologous outputs eliminate concern regarding pooled blood sources
The Department of Veterans Affairs requires a firm fixed price for the Plasmax Plasma Kits, with a delivery date of 30 days after receipt of the order.
• The system is designed for use in medical applications, particularly in situations where a higher fibrin concentration is required for optimal healing and recovery.
• The system's design ensures that the plasma concentrate is derived from the patient's own blood, providing a safer alternative to donor-based fibrin sealants.
• The system is notable for its elevated fibrinogen concentration, which is optimal for haemostasis.